Blood Glucose Monitoring Systems Market Size, Share & Industry Analysis, By Device (Continuous Blood Glucose Monitoring Systems, Self-monitoring of Blood Glucose Systems), By Type (Invasive, Non-invasive), By Modality (Wearable, Non-wearable), By Distribution Channel (Institutional Sales, Retail Sales), and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

                                          
We have updated Blood Glucose Monitoring Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Blood Glucose Monitoring market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Blood Glucose Monitoring market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Blood Glucose Monitoring Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Blood Glucose Monitoring Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Blood Glucose Monitoring Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

  
F. Hoffmann-La Roche Ltd.
  
Abbott
  
Ascensia Diabetes Care Holdings AG
  
Dexcom, Inc.
  
Medtronic
  
B. Braun Melsungen AG
  
Lifescan Inc.
  
Terumo Medical Corporation
  
DiamonTech GmbH

REPORT COVERAGE

landscape. Various key insights presented in the report are prevalence of diabetes for key countries and regions, new product launches, technological developments in blood glucose monitoring systems, recent industry developments, pricing of major products/brands, detailed product mapping for key market players, key strategies adopted by market leaders, competitive landscape and company profiles.

Report Scope & Segmentation

 Segmentation

By Device

  
Continuous Blood Glucose Monitoring Systems
  
Self-monitoring of Blood Glucose Monitoring Systems

By Type

  
Non-invasive
  
Invasive

By Modality

  
Wearable
  
Non-wearable

By Distribution Channel

  
Institutional Sales
  
Retail Sales

By Geography

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  
Latin America (Brazil, Mexico, and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

INDUSTRY DEVELOPMENT

October 2019: Dexcom announced that U.S Food and Drug Administration (FDA) cleared its G6 Pro continuous glucose monitoring (CGM) system for the use in diabetic patients with age of two years and above.

October 2018: Platinum Equity acquired LifeScan from Johnson & Johnsons diabetes care business, with an aim to increase its product offerings.

August 2018: Dexcom acquired TypeZero Technologies, which was an extension of the long partnership between the two companies with an aim to improve its product offerings through TyperZero Technologiesautomated insulin delivery system.

August 2017: ARKRAY USA announced the launch of the GLUCOCARD Shine XL blood glucose monitoring system (BGMS) for quick and easy viewing of blood glucose test results.